NCT02025413View on ClinicalTrials.gov

Isolation of Circulating Tumor Cells Using a Novel EMT-Based Capture Method

NACompletedINTERVENTIONAL

Enrollment

46

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Metastatic Progressive Castration-resistant Prostate CancerMetastatic Progressive Breast Cancer

Interventions

DEVICE

Mesenchymal-marker based ferrofluid (N-cadherin or O-cadherin based)

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

Collaborators (1)

Janssen Diagnostics, LLC

All Listed Sponsors

collaborator

Prostate Cancer Foundation

OTHER

collaborator

United States Department of Defense

FED

collaborator

Janssen Diagnostics, LLC

INDUSTRY

lead

Duke University

OTHER